John Rakolta in SEHA to Witness on global health field

The Abu Dhabi Health Services Company, “SEHA”, received John Rakolta, the US ambassador to the state, and his accompanying delegation, who were briefed on the latest developments regarding trials of the COVID-19 vaccine, in which the United Arab Emirates witnessed the third phase of clinical trials to prove the safety and effectiveness of the vaccine.

“SEHA” informs the American ambassador about the latest developments in COVID-19 vaccine trials

Dr. Marwan Al-Kaabi, Executive Director of Operations at the “SEHA” Company, Dr. Nawal Al-Kaabi, Executive Medical Director at Sheikh Khalifa Medical City affiliated to the “SEHA” Company, and Chair of the National Clinical Committee for “COVID-19”, met with the US Ambassador and Alison Delworth, The Economic Adviser, and Susan Holmes, Assistant in the Economics Department at the Embassy.

“John Rakolta” visits the SEHA

Dr. Marwan and Dr. Nawal accompanied the US ambassador and his accompanying delegation on a tour of the Abu Dhabi National Exhibition CenterADNEC“, where “SEHA” established a centre to conduct clinical trials and provided it with specialized health practitioners to supervise these experiments, under the supervision of the Abu Dhabi Department of Health, and the company ” G42 Healthcare is one of the subsidiaries of the G42 Group, as these experiences came in line with the vision of the wise leadership and its commitment to overcoming this global epidemic, and the UAE’s outstanding contributions in the global health field.

Dr. Nawal confirmed that “SEHA” has provided all means of success for clinical trials. Efforts have been made in the success of the experiments and in providing the necessary vaccine to combat the Coronavirus, as the state began providing the first dose of the vaccine to frontline workers, to add this achievement to its record of achievements in the field. Health.

John Rakolta is informed of the latest developments in the trials of the “COVID-19” vaccine in the UAE

His Excellency John Rakolta Junior, US Ambassador to the country – during his visit to the Abu Dhabi Health Services Company, “SEHA” – was briefed on the latest developments in the trials of the “COVID-19” vaccine, in which the UAE witnessed the third phase of clinical trials to prove its safety and effectiveness.

The “G42 Healthcare” company praised the great response by citizens and residents of the Emirates, who rushed to volunteer and participate in clinical trials in the “For Humanity” campaign, which had the greatest impact on the success of these experiments.

The third phase of clinical trials

It is noteworthy that the global clinical trials for the third stage of the COVID-19 vaccine produced by (Sinopharm CNBG) and “G42 Healthcare” was carried out within the framework of cooperation between the Department of Health – Abu Dhabi and the “SEHA” company, under the umbrella of the World Health Organization, and the efforts of The international cooperation that Abu Dhabi incubated as part of the commitment of the UAE government and health authorities to find a cure for the biggest challenge humanity has witnessed in the 21st century.

You might also like